BioAge Labs, Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses), averaging +16.9% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $-0.65 | $-0.58 | +10.8% | Beat | |
| Q1 FY26 | $-0.71 | $-0.52 | +26.8% | Beat | |
| Q4 FY25 | $-0.83 | $-0.72 | +13.3% | Beat |
Back to BIOA overview · BIOA holders · BIOA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.